Therapeutic Classes/Calcitonin Gene-related Peptide Receptor Antagonist

Calcitonin Gene-related Peptide Receptor Antagonist

8 drugs across 3 manufacturers|0 Generic,8 Brand

The Calcitonin Gene-related Peptide Receptor Antagonist class contains 8 NDCs from 3 manufacturers (0 generic, 8 brand), at an average NADAC of $95.10 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.

Total Drugs

8

0G / 8B

Manufacturers

3

Avg $95.0951/unit

Avg 7d Change

-0.05%

Across 8 drugs with changes

7d Activity

1↑7↓0 flat

of 8 total drugs

Class Price Trend

Monthly average NADAC price per unit, split by generic and brand

Manufacturer Breakdown

3 manufacturers producing drugs in this therapeutic class

Drug Portfolio

8 drugs total, 8 shown

Drug ↕Price 7d Change ↕
ZAVZPRET 10 MG NASAL SPRAY
zavegepant
$189.8006
per EA
-0.01%
NURTEC ODT 75 MG TABLET
rimegepant sulfate
$128.6698
per EA
+0.01%
UBRELVY 100 MG TABLET
ubrogepant
$109.1070
per EA
-0.03%
UBRELVY 100 MG TABLET
ubrogepant
$109.1070
per EA
-0.03%
UBRELVY 50 MG TABLET
ubrogepant
$108.8907
per EA
-0.02%
QULIPTA 60 MG TABLET
Atogepant
$38.4494
per EA
-0.01%
QULIPTA 30 MG TABLET
Atogepant
$38.3777
per EA
-0.04%
QULIPTA 10 MG TABLET
Atogepant
$38.3583
per EA
-0.18%

Follow this class across the site

These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.

Frequently Asked Questions

How many drugs are in the Calcitonin Gene-related Peptide Receptor Antagonist class?

The Calcitonin Gene-related Peptide Receptor Antagonist class contains 8 NDCs from 3 manufacturers — 0 generic and 8 brand products.

What is the average price of Calcitonin Gene-related Peptide Receptor Antagonist drugs?

The average NADAC for the Calcitonin Gene-related Peptide Receptor Antagonist class is $95.0951 per unit across 8 NDCs.

Which manufacturers make Calcitonin Gene-related Peptide Receptor Antagonist drugs?

3 manufacturers make drugs in the Calcitonin Gene-related Peptide Receptor Antagonist class. Ranked by number of NDCs, the largest are Allergan, Inc. (3), AbbVie Inc. (3), Pfizer Inc. (2).

How has Calcitonin Gene-related Peptide Receptor Antagonist pricing changed recently?

Over the past 7 days, 1 NDC in this class rose and 7 fell, with a class-wide average change of -0.1%.